Research output per year
Research output per year
Project Details
| Acronym | R8875PMY |
|---|---|
| Status | Finished |
| Effective start/end date | 01/11/2019 → 04/05/2021 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Furin as a therapeutic target in cystic fibrosis airways disease
Douglas, L. E. J., Reihill, J. A., Montgomery, B. M. & Martin, S. L., 30 Jun 2023, In: European Respiratory Review. 32, 168, 14 p., 220256.Research output: Contribution to journal › Review article › peer-review
Open AccessFile7 Downloads (Pure) -
Highly selective furin inhibition as a therapeutic approach for chronic obstructive pulmonary disease
Douglas, L., Reihill, J., Odrljin, T. & Martin, L., 01 Nov 2023, In: European Respiratory Journal. 62, suppl 67, PA1868.Research output: Contribution to journal › Meeting abstract › peer-review
-
Highly selective, first-in-class furin inhibitor BOS-318 inhibits ENaC and restores airway hydration in cystic fibrosis
Douglas, L., Reihill, J., Ho, M., Axten, J., Campobasso, N., Wilcoxen, K. & Martin, S., 01 Nov 2021, In: Journal of Cystic Fibrosis. 20, Supplement 2, p. S185 1 p., 391.Research output: Contribution to journal › Meeting abstract › peer-review
Activities
- 1 Participation in conference
-
2021 North American Cystic Fibrosis Conference (NACFC)
Lorraine Martin (Participant)
02 Nov 2021 → 05 Nov 2021Activity: Participating in or organising an event types › Participation in conference